Zoe K. McQuilten, Erica M. Wood, Mark N. Polizzotto, Lynda J. Campbell, Meaghan Wall, David J. Curtis, Helen Farrugia, John J. McNeil and Vijaya Sundararajan Underestimation of myelodysplastic syndrome incidence by cancer registries: Results from a population-based data linkage study Cancer 120
Previous reports have suggested that myelodysplastic syndromes (MDS) are underreported to cancer registries, and therefore may have a substantially higher incidence. However, whether these findings are broadly applicable is unknown. Using 2 data sources from a different population, a higher incidence of MDS was found than was reported using cancer registry notifications alone as well as differences between reported and nonreported cases.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf